United States - Re-Export of Penicillins or Streptomycins Not in Dosage Forms
Since 2014, United States Re-Export of Penicillins or Streptomycins Not in Dosage Forms was down by 25.7% year on year. At $108,118 in 2019, the country was ranked number 2 among other countries in Re-Export of Penicillins or Streptomycins Not in Dosage Forms. New Zealand topped the ranking with $476,039.52 in 2019, a fall of 2.3% compared to 2018. Guyana recorded the best 5 years average growth at +152% per year, while United States recorded the worst performance at -25.7% per year.
Loading...
Date | US Dollars |
---|---|
2019 | 108,118.00 |
2018 | 162,695.00 |
2017 | 264,949.00 |
2016 | 120,521.00 |
2015 | 144,833.00 |
Download all data from 1991 to 2019
How does United States rank in Re-Export of Penicillins or Streptomycins Not in Dosage Forms?
# | 11 Countries | US Dollars | Last | YoY | 5‑years CAGR | |
---|---|---|---|---|---|---|
1 |
#1
New Zealand
|
476,039.52 | 2019 | -2.3 % | -7.7 % | View data |
2 |
#2
United States
|
108,118.00 | 2019 | -33.5 % | -25.7 % | View data |
3 |
#3
Saudi Arabia
|
75,525.71 | 2019 | -63.2 % | NA | View data |
4 |
#4
United Arab Emirates
|
28,682.16 | 2019 | +139.1 % | +18.9 % | View data |
5 |
#5
Yemen
|
26,317.00 | 2015 | +2,726.8 % | NA | View data |